Northern Trust NTRS
Financial Services · Asset Management · Synthos Deep Dive · 2026-07-03
The Overview
Northern Trust is a 137-year-old Chicago bank for the wealthy and for big institutions. It doesn't chase risky loans — it holds and safeguards other people's money (over $18 trillion of assets it keeps custody of), runs their investments, and does private banking for rich families. It gets paid mostly in fees that go up and down with the stock and bond markets, plus interest on a very safe pile of deposits.
Is the stock cheap or expensive? Fairly priced — maybe slightly full. You're paying about 16 dollars for every 1 dollar of next year's profit, which is reasonable for a steady, high-quality bank, but the stock has already climbed a lot and now sits at its highest price of the year. Professional analysts mostly say "hold," not "buy."
Our verdict is Watch: a good company, but not obviously cheap, and we have no special insight (no expert analysts in our knowledge base cover it) that would let us bang the table.
Here's what our three scores mean in everyday terms:
- Downside Risk 4/10 (fairly low). Its funding is extremely safe (it sits on more cash than debt) and the price isn't stretched — but the stock does swing more than the market, and its earnings ride on where markets and interest rates go.
- Growth Quality 5/10 (middle). Profits are recovering nicely, but a lot of that comes from cutting costs and buying back shares, not from the business itself growing fast.
- Exponential Potential 3/10 (low). This is a mature, slow-and-steady franchise. Don't expect it to double quickly.
The one big worry: its fees depend on how high the markets are and how high interest rates are. A market crash or a run of rate cuts would squeeze both at the same time.
Putting a number on it: our fair-value estimate is $182 against a current price of $186.79 — a premium price for a business we still like.
Our summary metrics
Fortress deposit funding & net-cash, low absolute valuation (16× FY26E) — but beta 1.27, rate/market-linked fee base, and a Hold-rated Street.
~16% forward EPS CAGR off cost discipline & buybacks, but ~7% revenue CAGR — earnings quality, not organic engine.
A 137-year-old custodian at trough-to-recovery ROE; big TAM but no acceleration and asset-linked, not exponential.
What does “fair value” mean?
Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.
The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Exponential Potential
A 137-year-old custodian at trough-to-recovery ROE; big TAM but no acceleration and asset-linked, not exponential.
What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.
Deeper analysis
Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.
Reference table
| Street consensus | $162 (high $186 / low $148; 13 Buy · 17 Hold · 5 Sell → Hold) — context, not our anchor |
| Valuation | 18× trailing EPS · 16× FY26E · 15× FY27E · 13× FY28E · P/B 2.5× · ~1.8% dividend yield |
| Technicals | Uptrend — $176.5 at the 52-wk high, above 50/200-DMA, RSI 61, +37.9% 12-mo (SPY +20.6%) |
| Conviction | None — 0 net-bullish voices, 0 traceable claims in the Synthos KB; this is a quant/fundamental call |
| Position sizing | If owned, a ~1–3% income/quality satellite — not a high-conviction core |
What the experts actually said
No independent expert claims in the Synthos knowledge base yet for NTRS — this dive is fundamentals- and technicals-driven, not panel-driven.
Price & moving averages 12 months · 50 & 200-day averages · 52-week range
Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.
Data summary: last close $186.79, 2% above the 50-day average ($183), 19% above the 200-day average ($157) — an uptrend. 2% below the 52-week high of $191, 52% above the 52-week low of $123.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Data summary: price $186.79 is currently inside the band (band $181–$193).
RSI (14) momentum gauge · 0–100
Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 53.
MACD 12 / 26 / 9 · trend & momentum
The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.
Data summary: MACD is currently below its signal line by 0.45, negative momentum.
Relative performance vs S&P 500 & its sector (XLF (sector)), set to 100 a year ago
Solid = NTRS · dashed = S&P 500 · dotted = XLF (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
1. What it is
Northern Trust Corporation (NASDAQ: NTRS) is a financial-holding company founded in 1889 and headquartered in Chicago. It is not a lend-heavy commercial bank; it is a trust bank — a custodian, asset servicer, asset manager and private-wealth franchise. It safeguards and administers assets, runs money for institutions and wealthy families, and funds itself with an unusually stable, low-cost deposit base. Fiscal year ends December 31. CEO: Michael O'Grady.
Scale markers from the Q1'26 release: Assets Under Custody / Administration ~$18.6 trillion, Assets Under Custody ~$14.8 trillion, and Assets Under Management ~$1.78 trillion. Trust, investment and other servicing fees — the largest revenue line — run off these balances (with a one-month/one-quarter lag), so fee revenue is directly levered to market levels.
Two reporting segments (FY2025 servicing-fee/segment revenue basis, from FMP segmentation):
- Asset Servicing (a.k.a. Corporate & Institutional Services) — custody, fund administration, outsourced investment operations, securities lending, FX, treasury and banking for institutions. FY25 ~$4.76B (≈59% of segment revenue).
- Wealth Management — trust, investment management, custody, private/business banking, philanthropic and family-office services for high-net-worth families. FY25 ~$3.38B (≈41%).
By geography (FY2025 pre-tax income split, FMP): Domestic ~$5.65B vs Foreign ~$2.43B — roughly 70% US / 30% international. The international asset-servicing footprint (Europe/APAC custody) is a genuine differentiator but adds FX and cross-border operational exposure.
2. The expert thesis
There is no expert coverage of NTRS in the Synthos knowledge base. total_claims = 0, net_bullish_voices = 0, and the top array is empty. No independent, skill-weighted voice in our panel is on record for or against this name.
That is stated plainly and honestly: this verdict is fundamentals- and quant-driven, not conviction-driven. There are no claim_id values to cite because none exist for NTRS, and House Standard forbids fabricating conviction. Where a name like Eli Lilly earns a "Buy — Core" on 13 net-bullish voices and 251 reconciled claims, Northern Trust earns a Watch on the numbers alone — a solid, well-run franchise that our expert panel simply hasn't flagged as an edge in either direction. Absence of coverage is not a negative signal; it is the absence of a signal, and we size and rate accordingly (smaller, more cautious, no table-pounding).
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 4 · Low–Moderate | Net-cash balance sheet (net debt −$44.7B), fortress deposit funding, current ratio 4.3×, and an undemanding ~16× FY26E cushion the downside; offsetting that, beta 1.27, a fee base levered to markets+rates, and a stock at its 52-week high with a Hold-rated Street. |
| Growth Quality | 5 · Moderate | Forward EPS CAGR ~16% (FY25 $8.79 → FY29E $16.01) and a Q1'26 ROE of 17.4% are genuinely good — but revenue CAGR is only ~7%, so much of the EPS growth is cost leverage + buybacks, not an organic engine. Quality yes; compounding-machine no. |
| Exponential Potential | 3 · Low | A 137-year-old custodian at cyclical-recovery ROE. Big absolute TAM (global custody/wealth) but no acceleration — second derivative of revenue growth is roughly flat-to-down, and fees are asset-linked. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | Markets keep rising (fee tailwind), rates stay higher-for-longer (NII holds), operating leverage extends, buybacks continue at 100% payout. FY27E EPS beats to ~$13.0; multiple re-rates toward ~17.5× (peer-premium for quality). | ~$226 (+28%) |
| Base (our anchor) | Estimates roughly hit — FY26E EPS $11.02, FY27E $12.12; a steady mid-teens-ROE trust bank earns a modest ~15× on ~FY27 power. | ~$182 (+3%) |
| Bear | Market drawdown + rate cuts compress fees and NII together; operating leverage reverses; EPS stalls near ~$10.5. Multiple de-rates to ~12×. | ~$128 (−27%) |
Synthos fair value = the base case, ~$182 (+3%), with the full $128–$226 span as the honest range. Note our base sits above the Street's $162 consensus (we give more weight to the FY27 earnings-power the Street's own estimates imply) but only modestly, and our bull is near the Street's $186 high. The thin +3% base-case upside is precisely why this is a Watch: the quality is real, but at the 52-week high there is little margin of safety. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). NTRS is neither a fast compounder nor an exponential — it is a mature, cyclical-quality franchise in a mid-cycle earnings recovery:
- Forward growth: revenue CAGR FY25→FY29E ~6.7% (FTE ~$8.0B → ~$10.4B); EPS CAGR ~16.2% ($8.79 → $16.01E) — the gap between the two is the tell: earnings growth is powered by margin/operating leverage and share-count reduction, not by the top line.
- Acceleration (the 2nd derivative) is flat-to-negative: consensus EPS growth is +25% (FY26E) → +10% (FY27E) → +13% (FY28E) — no durable acceleration; it is a recovery normalizing, not an inflection. Per our flagship philosophy we hunt forward next-exponentials with a positive second derivative; NTRS does not qualify.
- Room to run: the addressable market (global asset custody + wealth) is enormous, and at a $32.7B cap NTRS is not size-constrained in principle — but its revenue is asset-linked, so it grows roughly with markets + net flows, not exponentially. There is no structural reason for it to 3× on its own dynamics.
- Reinvestment runway: capital is returned, not reinvested for growth — 100% of Q1'26 earnings returned to shareholders (dividends + buybacks). That is shareholder-friendly and appropriate for the business, but it is the opposite of a high-reinvestment exponential.
Exponential Potential: Low (3/10). Own it (if at all) for steady mid-teens ROE, a growing dividend and buyback-driven EPS — not for a multibagger. Honest framing: this is an income/quality satellite, not a Degen-tier or even a core-growth name.
5. Financials (real numbers — FMP annual/quarterly + Q1'26 earnings release)
- Earnings (the clean story): FY25 net income $1.74B, diluted EPS $8.74. The recovery is vivid in the quarterly path: Q1'25 $1.90 → Q2 $2.13 → Q3 $2.29 → Q4 $2.42 → Q1'26 $2.71 diluted EPS. Q1'26 net income $525.5M, up 34% YoY, on 14% revenue growth and 700+ bps of operating leverage (management's words, §9).
- Revenue (mind the accounting): on an FTE/total basis, ~$8.1B FY25 and $2.21B in Q1'26 (+14% YoY). Trust/investment/servicing fees $1,341M (largest line) + net interest income (FTE) $662M + other noninterest income $210M. (The FMP $14.3B "revenue" line grosses up interest income and is not the right denominator for margins.)
- Profitability: Q1'26 pre-tax margin 32.0% (up 4.9 pts YoY) and ROE 17.4% (up from 13.0% a year ago) — a strong cyclical recovery. TTM net margin ~12.8% on the gross-revenue base; ROE TTM 14.5%.
- Client assets (the fee driver): AUC/A ~$18.6T (+10% YoY), AUM ~$1.78T (+11% YoY) — growth driven by favorable markets plus net inflows. This is the double-edged core: it lifts fees in up-markets and cuts them in down-markets.
- Balance sheet / funding: net cash, not net debt — net debt −$44.7B (cash & ST investments ~$63.8B vs total debt $16.4B); current ratio 4.3×. A deposit-funded trust bank with a conservative, high-quality securities book. Total assets $177B, equity $13.0B.
- Capital return: dividend $3.20/share (~1.8% yield), payout ratio ~34%; FY25 buybacks ~$1.27B; 100% of earnings returned in Q1'26.
6. Valuation — priced in or room?
On its own multiple NTRS is reasonable, not a bargain. It trades at ~18× trailing EPS ($176.50 / ~$9.60 TTM) and, on live consensus, ~16× FY26E ($11.02) → ~15× FY27E ($12.12) → ~13× FY28E ($13.66). Price/book is 2.5× against a mid-teens ROE — a fair, not cheap, franchise multiple. The PEG on trailing metrics is distorted by the recovery; on forward EPS CAGR (~16%) a ~15–16× forward P/E is close to fairly valued.
The bull case for the multiple is that a durable 17%+ ROE trust bank with a net-cash balance sheet deserves a premium to a plain-vanilla regional bank; the bear case is that the ROE recovery is rate- and market-cycle-aided and could mean-revert, in which case ~16× on peak-ish earnings is full. Street targets (context): consensus $162, high $186, low $148, with grades skewed to Hold (13 Buy / 17 Hold / 5 Sell) — the Street sees the stock as roughly fairly valued after the run, which aligns with our modest +3% base-case upside. Not a value buy, not an obvious short — a fairly-priced quality name, which is the essence of a Watch.
7. Technicals (from the FMP tech block)
- Trend: up. $176.50 sits above the 50-DMA ($168.5) and 200-DMA ($146.0), and the 50 is above the 200 (golden-cross posture). MACD +2.39 (positive).
- Location: at the 52-week high ($176.50) — 0.0% off the peak, +43.8% off the 52-week low ($122.72), essentially no drawdown from peak. A leadership posture, but also a stretched entry point (no margin of safety on price).
- Momentum: RSI(14) 61 — firm but not overbought (<70).
- Relative strength: NTRS +37.9% 12-mo vs SPY +20.6% (and vs QQQ +30.3%); +24.8% 3-mo vs SPY +13.7%. Real outperformance of the broad market over the past year.
- Read: technicals are constructive and confirm the earnings recovery, but the stock is at highs with no pullback cushion — a technical argument to wait for a dip toward the rising 50-DMA (~$168) rather than chase, consistent with the Watch verdict.
8. Moat & competitive position
Northern Trust's moat is trust, scale and switching costs, not a product edge. Custody and asset servicing are sticky, operationally embedded, high-switching-cost relationships; a ~137-year brand with a conservative reputation matters to the endowments, sovereign funds, and ultra-high-net-worth families it serves. It is a member of the small global custody oligopoly (with State Street and BNY at the mega-custodian tier), and its Wealth Management arm is a premium private-banking franchise. The weaknesses of the moat: custody is a scale/fee-compression business (basis points on assets, competed hard), and revenue is beta to markets and rates rather than to a proprietary advantage.
Peer set (FMP peers, market cap): State Street $47.2B (the closest custody comp), U.S. Bancorp $95.8B, Citizens Financial $30.0B, T. Rowe Price $25.4B (asset-management comp), First Citizens BancShares $24.1B, Markel $24.8B, Cincinnati Financial $29.7B, Carlyle Group $15.4B, Blue Owl $14.1B. Within trust/custody, NTRS's mid-teens/17% ROE and net-cash funding stack up well; its ~16× forward P/E is a modest premium to plain regionals and roughly in line with quality trust-bank peers.
9. Management, capital allocation & guidance
- Capital allocation: shareholder-return-first — dividend (~1.8% yield, ~34% payout) plus buybacks, with 100% of Q1'26 earnings returned to shareholders. Consistent with a mature, capital-generative trust bank; not a growth-reinvestment story.
- Insider activity: the recent Form-4 flow (filings 2026-07-02) is routine director stock awards (A-Award, e.g. Tribbett, Thompson, Slark, Harrison), not open-market discretionary buying or a selling cluster — no directional signal.
- Management's own guidance (half-weighted — their own book): the Q1'26 earnings release (SEC 8-K Item 2.02, filed 2026-04-21) is a real earnings release but, consistent with Northern Trust's practice, it contains commentary rather than explicit numeric forward guidance. CEO Michael O'Grady's own words: "Northern Trust began 2026 with strong financial momentum… Revenue increased 14% year-over-year… Disciplined expense management and a sustained focus on operational efficiency generated more than 700 basis points of operating leverage, a 32% pre-tax margin, and a 43% rise in earnings per share. Return on equity reached 17.4% and we returned 100% of our earnings to shareholders." Treat this as management's self-interested framing (half-weight): it confirms the recovery and the operating-leverage theme but offers no forward revenue/EPS target. Numeric management guidance was not available — the analysis relies on Street consensus for forward figures, labeled as estimates.
10. Catalysts & what to watch
- Next earnings: 2026-07-22 (Q2'26; Street EPS $2.66). Watch: trust/servicing fee growth, net interest income trajectory, and whether the 700-bps operating-leverage story persists.
- Rates: the path of Fed policy — rate cuts would pressure net interest income; higher-for-longer supports it.
- Markets: equity/bond levels drive AUC/A and AUM (lagged), hence fee revenue — a drawdown is the key downside trigger.
- Operating leverage: management has leaned hard on expense discipline; a reversal (or a re-acceleration of costs) would undercut the EPS-recovery thesis.
- Capital return: continuation of the 100%-payout / buyback cadence supports EPS.
Thesis tripwires (what would change the call): two consecutive quarters of fee-revenue decline; net-interest-income compression from rate cuts not offset by volume; operating leverage turning negative; or a re-rating that pushes the multiple to a level with clearly negative expected return.
11. Key risks
- Market/rate sensitivity (structural): fee revenue is levered to market levels (AUC/A, AUM) and NII to rates — a drawdown or a cutting cycle compresses both at once. This is the single biggest risk.
- Cyclical, recovery-aided ROE: the 17% Q1'26 ROE is a cyclical high aided by favorable rates/markets; mean reversion would make ~16× look full.
- Fee compression: custody/asset-servicing is a competitive basis-points business under secular pricing pressure.
- Beta / valuation: beta 1.27 and a stock at its 52-week high mean limited price cushion if sentiment turns.
- No expert edge: we have zero KB coverage — no independent conviction (bullish or bearish) to lean on; the call rests entirely on fundamentals and quant.
12. Verdict, position sizing & monitoring
Watch. Northern Trust is a genuinely high-quality, deposit-funded custody-and-wealth franchise in a real earnings recovery (Q1'26 ROE 17.4%, +34% net income, 700 bps of operating leverage), with a fortress net-cash balance sheet and a reasonable ~16× forward multiple. But three things hold it back from a Buy: (1) the stock is at its 52-week high with only ~+3% base-case upside and no price cushion; (2) the Street rates it Hold and our fair value sits only modestly above consensus; and (3) our expert panel does not cover it, so there is no conviction edge to justify table-pounding. Quality without a margin of safety and without an edge is a Watch, not a Buy.
- Sizing: if owned, an income/quality satellite, ~1–3% — not a core position. The cleaner entry is on a pullback toward the rising 50-DMA (~$168) or on a fee-revenue/ROE confirmation at Q2'26.
- Monitoring: re-underwrite on the tripwires in §10; formal re-score each earnings print. Upgrade path to Buy — Tactical: a market pullback that resets the multiple toward ~13× forward while the ROE/operating-leverage story holds. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $176.50.
- Single biggest risk: a simultaneous market drawdown and rate-cut cycle that compresses fees and net interest income together.
Provenance & disclosures
- Traceability: 0 KB claims, breadth 0 — no expert coverage exists for NTRS in the Synthos knowledge base, so no
claim_ids are cited. This is disclosed as a fundamentals/quant-only call. Fabricated conviction is structurally impossible (claim-ID reconciliation), and here there simply is none to reconcile. - Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · Q1'26 earnings release (SEC 8-K) 2026-04-21. Forward figures are analyst consensus (FMP), labeled as estimates.
- Accounting note: FMP's income-statement "revenue" grosses up interest income; organic trends and margins here use the fully-taxable-equivalent / segment revenue (~$8.1B FY25, $2.21B Q1'26) from the earnings release.
- Management caveat: the CEO commentary in §9 is management's own book, half-weighted by design; no numeric forward guidance was provided.
- Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
- Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").